Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

GlucoTrack, Inc. (GCTK)

0.4954   0.085 (20.83%) 03-24 16:00
Open: 0.413 Pre. Close: 0.41
High: 0.66 Low: 0.3715
Volume: 172,922 Market Cap: 8(M)

Technical analysis

as of: 2023-03-24 4:26:21 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.08     One year: 1.5
Support: Support1: 0.34    Support2: 0.29
Resistance: Resistance1: 0.93    Resistance2: 1.28
Pivot: 0.54
Moving Average: MA(5): 0.43     MA(20): 0.71
MA(100): 1.33     MA(250): 1.97
MACD: MACD(12,26): -0.3     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 11.1     %D(3): 9.3
RSI: RSI(14): 30.2
52-week: High: 4.23  Low: 0.34
Average Vol(K): 3-Month: 14 (K)  10-Days: 34 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ GCTK ] has closed above bottom band by 43.6%. Bollinger Bands are 111.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 12 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.66 - 0.66 0.66 - 0.67
Low: 0.37 - 0.37 0.37 - 0.37
Close: 0.49 - 0.5 0.5 - 0.5

Company Description

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Headline News

Tue, 14 Mar 2023

Fri, 10 Mar 2023
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are ... - UK

Mon, 10 Oct 2022

Wed, 22 Jun 2022
GlucoTrack, Inc. Provides Development Update on its Gen 2 Non ... - GlobeNewswire

Thu, 17 Mar 2022
Best Stocks Under $5 Right Now • Benzinga - Investing - Benzinga

Mon, 14 Mar 2022
GlucoTrack, Inc. Announces Effectiveness of Corporate Name ... - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 16 (M)
Shares Float 10 (M)
% Held by Insiders 33.8 (%)
% Held by Institutions 0.3 (%)
Shares Short 4 (K)
Shares Short P.Month 9 (K)

Stock Financials

EPS -0.26
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.15
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -52.2
Return on Equity (ttm) -105.1
Qtrly Rev. Growth 0
Gross Profit (p.s.) -0.01
Sales Per Share 0
EBITDA (p.s.) -0.3
Qtrly Earnings Growth 0
Operating Cash Flow -4 (M)
Levered Free Cash Flow -2 (M)

Stock Valuations

PE Ratio -1.91
PEG Ratio 0
Price to Book value 3.3
Price to Sales 0
Price to Cash Flow -2.05

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.